Avingtrans

Avingtrans designs, manufactures, and services performance-critical power, pump, and process solutions for global energy systems.

Avingtrans’ Medical and Industrial Imaging division produces compact MRI and 3D X-ray systems, including FDA-approved orthopedic imaging.

Adaptix Ltd partnered with Spartan Medical to distribute its Orthopedic 3D Imaging System to federal healthcare providers.

Avingtrans acquired Joseph Oat Corporation’s nuclear engineering intellectual property, trading history, and brand.

Metalcraft obtained a £3.6 million framework contract with Cummins Inc. for its Energy Division.

Hayward Tyler won a US$6.7 million contract from Korea Hydro & Nuclear Power for pump spare parts.

Maloney Metalcraft acquired intellectual property and assets from the Ormandy Group for integration into its business.

Metalcraft secured a £11 million contract extension with Sellafield Ltd.

Jo Reedman joined Avingtrans’ board as an independent non-executive director on March 1, 2022.

Stephen King Chief Financial Officer and Company Secretary

Appointed to the board as Non-executive Director on 22 February 2008, Roger McDowell became Chairman in March 2008. After University Roger worked for some 20 years with Oliver Ashworth Ltd., a pipeline products distributor, where he became MD and was instrumental in growing sales from £1 million to over £100 million and achieving a full listing on the London Stock Exchange. Roger has held a number of non-executive appointments in both private, Official List and AIM quoted companies across a dive

*figures based on FY2026 continuing operations

Avingtrans plc Chatteris Business Park, Chatteris. Cambridgeshire, PE16 6SA

Avingtrans plc has a proven strategy of “buy and build” in highly regulated engineering markets, a strategy it has named “Pinpoint-Invest-Exit”.

Avingtrans commits to protecting user privacy and does not sell personal information to other businesses.

Avingtrans plc acquires the intellectual property, trading history, and brand of Joseph Oat Corporation, a U.S.-based nuclear engineering specialist, for **$2.5 million in cash**. The deal expands Avingtrans’ offerings in nuclear components and systems for energy, medical, and industrial sectors. Joseph Oat Corporation’s expertise complements Avingtrans’ existing portfolio of critical engineering solutions.

Oct 2026Avingtrans PLCNews article

Avingtrans achieves a record annual revenue of **£163.3 million** for the year ending May 31, 2026, marking a **4.4% increase** from the prior year. Growth stems from expansions in its **energy division** and **medical operations**, driving higher sales. The company also reports adjusted EBITDA of **£20.7 million** for the period.

Sep 2026Yahoo Finance UKNews article

Avingtrans PLC raised **£21 million in equity funding** in July 2026 to accelerate growth in its **US nuclear engineering operations**. The capital supports expansion efforts in a sector marked by rising demand for nuclear infrastructure projects. The company, listed on the London Stock Exchange’s AIM market, plans to deploy the funds toward scaling its nuclear capacity while preparing to report full-year financial results on **30 September 2026**.

Sep 2026KalkineNews article

Adaptix Ltd partners with Spartan Medical to distribute its **Orthopedic 3D Imaging System (Adaptix Ortho350)** in the U.S., targeting federal sector adoption. The collaboration aims to broaden access to portable 3D imaging solutions for orthopedic applications. Adaptix, a subsidiary of Avingtrans plc, specializes in medical device innovation.

Jul 2026Avingtrans PLCNews article